News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,105 Results
Type
Article (88470)
Company Profile (813)
Press Release (788792)
Multimedia
Podcasts (223)
Webinars (34)
Section
Business (233454)
Career Advice (4156)
Deals (39932)
Drug Delivery (170)
Drug Development (91581)
Employer Resources (207)
FDA (18493)
Job Trends (17462)
News (398410)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (179)
Alliances (56986)
ALS (213)
Alzheimer's disease (1903)
Antibody-drug conjugate (ADC) (473)
Approvals (18756)
Artificial intelligence (771)
Autoimmune disease (274)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (230)
Biotechnology (486)
Bladder cancer (192)
Brain cancer (78)
Breast cancer (750)
Cancer (5935)
Cardiovascular disease (515)
Career advice (3586)
Career pathing (48)
CAR-T (342)
CDC (73)
Celiac Disease (2)
Cell therapy (941)
Cervical cancer (46)
Clinical research (78126)
Collaboration (2190)
Company closure (7)
Compensation (1362)
Complete response letters (97)
COVID-19 (3021)
CRISPR (112)
C-suite (1122)
Cystic fibrosis (161)
Data (7619)
Decentralized trials (3)
Denatured (83)
Depression (181)
Dermatology (72)
Diabetes (606)
Diagnostics (7462)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (384)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (289)
Earnings (101477)
Editorial (74)
Employer branding (25)
Employer resources (174)
Events (136977)
Executive appointments (1132)
FDA (22209)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1793)
Gene editing (243)
Generative AI (85)
Gene therapy (773)
GLP-1 (1224)
Government (5525)
Grass and pollen (8)
Guidances (406)
Healthcare (21062)
HIV (85)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (334)
Immuno-oncology (97)
Indications (167)
Infectious disease (3388)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (289)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (107)
Layoffs (673)
Leadership (47)
Legal (10169)
Liver cancer (106)
Longevity (32)
Lung cancer (792)
Lymphoma (426)
Machine learning (59)
Management (66)
Manufacturing (1067)
MASH (196)
Medical device (15180)
Medtech (15269)
Mergers & acquisitions (23163)
Metabolic disorders (1628)
mRNA (231)
Multiple sclerosis (190)
NASH (24)
Neurodegenerative disease (445)
Neuropsychiatric disorders (120)
Neuroscience (3486)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (794)
Opinion (363)
Ovarian cancer (210)
Pain (263)
Pancreatic cancer (288)
Parkinson's disease (377)
Partnered (39)
Patents (598)
Patient recruitment (655)
Peanut (66)
People (67566)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24143)
Phase 2 (33922)
Phase 3 (25516)
Pipeline (7834)
Policy (378)
Postmarket research (3556)
Preclinical (10860)
Press Release (72)
Prostate cancer (300)
Psychedelics (64)
Radiopharmaceuticals (344)
Rare diseases (1144)
Real estate (7449)
Recruiting (81)
Regulatory (29854)
Reports (75)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (25)
RSV (98)
Schizophrenia (183)
Series A (299)
Series B (220)
Service/supplier (30)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4353)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (137)
Vaccines (1248)
Venture capital (115)
Weight loss (546)
Women's health (123)
Worklife (24)
Date
Today (170)
Last 7 days (821)
Last 30 days (2945)
Last 365 days (33253)
2026 (10437)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57665)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1294)
Alabama (100)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (51977)
Australia (9136)
California (13151)
Canada (3737)
China (1391)
Colorado (568)
Connecticut (582)
Delaware (400)
Europe (119700)
Florida (1952)
Georgia (428)
Hawaii (4)
Idaho (69)
Illinois (1127)
India (95)
Indiana (618)
Iowa (25)
Japan (530)
Kansas (138)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1613)
Massachusetts (9611)
Michigan (397)
Minnesota (741)
Mississippi (7)
Missouri (159)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (92)
New Jersey (3526)
New Mexico (33)
New York (3474)
North Carolina (1789)
North Dakota (10)
Northern California (6444)
Ohio (406)
Oklahoma (26)
Oregon (55)
Pennsylvania (2626)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (85)
South Dakota (2)
Southern California (5129)
Tennessee (210)
Texas (2121)
United States (47267)
Utah (394)
Vermont (1)
Virginia (334)
Washington D.C. (88)
Washington State (1087)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 878,105 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients
With a greenlight for ibogaine to enter clinical testing and three unnamed products set to receive Commissioner’s National Priority Vouchers this week, it’s full speed ahead for psychedelics. But will sidestepping normal regulatory protocols actually be a net negative for the field?
April 22, 2026
·
8 min read
·
Heather McKenzie
Leadership
The 4 biggest hiring mistakes biopharma executives keep making
Finding the right people for critical open roles can be difficult even for biopharma leaders. In this column, Kaye/Bassman’s Michael Pietrack discusses four pitfalls executives face during the hiring process, starting with confusing scientific brilliance with leadership ability.
April 22, 2026
·
5 min read
·
Michael Pietrack
Layoff Tracker
Replimune lays off over 200 in Massachusetts
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
April 22, 2026
·
50 min read
·
BioSpace Editorial Staff
rare diseases
Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision
The pivotal study of zilganersen in Alexander disease missed a secondary endpoint, but analysts expect the FDA to approve the asset given the unmet need and overall data.
April 22, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates
April 22, 2026
·
5 min read
Press Releases
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio
April 22, 2026
·
6 min read
Press Releases
Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026
April 22, 2026
·
1 min read
Press Releases
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
April 22, 2026
·
8 min read
Press Releases
Veristat to Acquire Certara’s Regulatory and Medical Writing Business
April 22, 2026
·
2 min read
Business
Lilly exits Rigel alliance, adding to RIPK1 scrap heap
Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October last year pulled the plug on one of these programs for central nervous system indications.
April 22, 2026
·
2 min read
·
Tristan Manalac
1 of 87,811
Next
